RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Akira Kawamura to Anticholesteremic Agents

This is a "connection" page, showing publications Akira Kawamura has written about Anticholesteremic Agents.
Connection Strength

0.194
  1. Arimura T, Miura S, Ike A, Sugihara M, Iwata A, Nishikawa H, Kawamura A, Saku K. Comparison of the efficacy and safety of statin and statin/ezetimibe therapy after coronary stent implantation in patients with stable angina. J Cardiol. 2012 Aug; 60(2):111-8.
    View in: PubMed
    Score: 0.104
  2. Mitsutake R, Miura S, Okamura K, Niimura H, Kawamura A, Saku K. Successful intensive lipid-lowering therapy using atorvastatin stabilizes coronary artery plaque as assessed by multi-detector row computed tomography. Intern Med. 2007; 46(12):859-63.
    View in: PubMed
    Score: 0.074
  3. Fujino M, Miura S, Matsuo Y, Tanigawa H, Kawamura A, Saku K. Pitavastatin-induced downregulation of CCR2 and CCR5 in monocytes is associated with the arrest of cell-cycle in S phase. Atherosclerosis. 2006 Aug; 187(2):301-8.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support